Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CPA3 | P15088 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL3192561 | 0.94 | CYP2D6 (0.44) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| SCHEMBL3206596 | 0.91 | ALDH1A1 (0.42) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| SCHEMBL3209366 | 0.91 | ALDH1A1 (0.42) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| Glycerin SCHEMBL3214162 | 0.89 | ALDH1A1 (0.41) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| Glycerin SCHEMBL3213893 | 0.89 | ALDH1A1 (0.41) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| SCHEMBL877721 | 0.89 | FFAR1 (0.50) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| SCHEMBL27944397 | 0.88 | HDAC3 (0.47) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| Propylene Glycol SCHEMBL3212556 | 0.88 | ALDH1A1 (0.40) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| SCHEMBL3204228 | 0.87 | NAALAD2 (0.41) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR | |
| SCHEMBL3215253 | 0.87 | NAALAD2 (0.44) | CYP2D6ALDH1A1CYP2C19CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2619177-A1 | MATRIX METALLOPROTEINASE INHIBITORS | Ranbaxy Laboratories Limited (IN) | 2013-07-31 | — | — | EP | claimed |
| WO-2012038943-A1 | MATRIX METALLOPROTEINASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2012-03-29 | — | — | WO | claimed |
| CN-115989455-A | Lithographic printing plate precursor | 爱克发胶印有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-103415507-A | 3-amino-pyridines as GPBAR1 agonists | HOFFMANN LA ROCHE | 2013-11-27 | — | — | CN | disclosed |
| EP-2619177-A1 | MATRIX METALLOPROTEINASE INHIBITORS | Ranbaxy Laboratories Limited (IN) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012038943-A1 | MATRIX METALLOPROTEINASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2012-03-29 | — | — | WO | disclosed |
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | SHOWA DENKO K.K. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2030989-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING THIOL COMPOUND | Showa Denko K.K. (JP) | 2009-03-04 | — | — | EP | disclosed |
| WO-2002095044-A2 | LIPASE CATALYZED ESTERIFICATION, TRANSESTERIFICATION, AND HYDROLYSIS OF ARYLTHIOLS AND ARYL-THIOESTERS | MOLECULAR ELECTRONICS CORPORATION (US) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | TMT1A, CCNT1, MGMT | CYP2D6 4344/4885ALDH1A1 124/4885CYP2C19 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.